Heart valve disease represents a diverse spectrum of conditions that pose significant challenges to cardiovascular health. While some cases of valve disease may remain asymptomatic for a long time, others can progress to severe complications, including heart failure. The management of heart valve disease often involves a collaborative effort among cardiologists, cardiac surgeons, and other healthcare professionals. Advances in medical technology have led to the development of less invasive procedures, such as transcatheter aortic valve replacement (TAVR), providing viable options for certain patients who may not be suitable candidates for traditional open-heart surgery. Ongoing research aims to enhance our understanding of the underlying mechanisms of valve disease and explore novel therapeutic approaches. Regular monitoring, early intervention, and personalized treatment plans are crucial elements in the comprehensive care of individuals with heart valve disease, emphasizing the importance of a multidisciplinary and patient-centered approach in addressing the complexities of this cardiovascular condition.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China